vimarsana.com

Page 50 - மாற்று அறுவை சிகிச்சை வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New INNCO Position Paper Outlines Why Bans on Popular Alternatives to Smoking Will Do More Harm Than Good

(1) Denying Access to Safer Nicotine Products in Low- and Middle-Income Countries Will Endanger the Lives of 800 Million People GENEVE, CH, Mar 17, 2021 - (ACN Newswire) - via NewMediaWire - The International Network of Nicotine Consumer Organisations (INNCO), a global association advocating for sensible tobacco harm reduction policies, today introduced a new position paper, 10 Reasons Why Blanket Bans of E-Cigarettes and HTPs in Low- and Middle-Income Countries (LMICs) Are Not Fit for Purpose. Available for download on the organisation s website (https://innco.org/why-bans-in-low-middle-income-countries-dont-work/), the policy report rebukes the overly simplistic and impractical bans on electronic nicotine delivery systems (ENDS) and other tobacco harm reduction (THR) products in LMICs, warning organizations and governments that limiting options to reduce harm will only increase the number of people smoking tobacco, inevitably leading to illicit markets and increases in crime

Amobee Partners with InfoSum to Power Win-Win Alternative Identity Solutions for Advertisers and Media Owners

Amobee Partners with InfoSum to Power Win-Win Alternative Identity Solutions for Advertisers and Media Owners Scalable, Cross-Screen Advertising Options Meet Decentralized Customer Data Ecosystem Tools to Guard Against Third-Party Cookie Deprecation Amobee, a global leader in advertising technology that unifies TV, digital and social to deliver results that drive customer growth, today announced a partnership with InfoSum, the world s leading identity infrastructure provider, to bring alternative, privacy-compliant identity solutions to advertiser and broadcaster clients around the world. The partnership will allow both Amobee and InfoSum to jointly offer their respective clients access to leading identity and media buying solutions through InfoSum s powerful decentralized customer data ecosystem, and Amobee s cross-screen, programmatic and broadcaster-centric advertising platform.

Gwen Stefani still feels heartbreak of Tragic Kingdom songs

4 d Share with: Gwen Stefani had mixed emotions marking the 25th anniversary of No Doubt album Tragic Kingdom last year, because the songs still leave her feeling a little heartbroken. The singer detailed her split from her bandmate Tony Kanal on the project, and even though they have both long moved on, celebrating its release milestone didn t feel quite right for Stefani. The whole purpose for the Tragic Kingdom is the breakup, the heartbreak. There s a lot of feelings, she shared on U.S. late night show Jimmy Kimmel Live!. Even in that record, when you say the words tragic kingdom, my heart still kind of is broken. Cause those songs were about a really sad time for me, she explained.

Conformis, Inc : Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants

(2) Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal knee replacement implants enable expedited surgical time and reduce length of hospital stay. BILLERICA, Mass., March 17, 2021 (GLOBE NEWSWIRE) Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants. Importantly, this study was independently performed with no sponsorship or funding from Conformis. The new abstract was presented by authors at the Orthopaedic Research Society 2021 Annual Meeting (ORS 2021 Annual Meeting), held in February 2021: Custom-designed total knee arthroplasty is cost-effective in comparison to a standard implant (https://www.ors.org/Transactions/67/980.pdf), Navin Fernando MD, Ann Chancellor CCRC, Paul Manner MD, University of Washingt

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.